Global Follicular Lymphoma Therapeutics Market 2018-2022
About Follicular Lymphoma
Follicular lymphoma is a subtype of B-cell non-Hodgkin lymphoma (NHL). It is usually indolent (slow-growing) and the tumor cells grow as groups to form nodules. Symptoms of follicular lymphoma include enlarged lymph nodes, shortness of breath, fever, night sweats, and weight loss.
Technavio’s analysts forecast the Global Follicular Lymphoma Therapeutics Market to at a CAGR of 7.50% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the follicular lymphoma therapeutics market. To calculate the market size, the report considers the revenue generated from the application of follicular lymphoma therapeutics across the globe.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report - Global Follicular Lymphoma Therapeutics Market 2018-2022
Technavio recognizes the following companies as the key players in the global follicular lymphoma therapeutics market: Bayer, Biogen, F. Hoffmann-La Roche, Gilead, and Merck.
Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market are the increasing patient programs. Some of the top pharmaceutical companies are offering patient support programs to provide information about the best therapeutics to increase the awareness about the treatment and range of cost.”
According to the report, one driver influencing this market is the increasing government initiatives. The global follicular lymphoma therapeutics market is likely to be driven by rise in government funded initiatives such as Cancer Breakthrough 2020.
Further, the report states that one challenge affecting this market is the high cost of treatment. The high cost of the available marketed products is expected to pose a challenge for the growth of the global follicular lymphoma therapeutics market.
F. Hoffmann-La Roche
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook